Innovation
Johnson Matthey and Sinopec Capital explore strategic collaboration across decarbonisation and hydrogen technologies
Johnson Matthey China and Sinopec Capital signs a Memorandum of Understanding (MoU) signaling the start of active dialogues to explore joint possibilities across green and blue hydrogen, fuel cells, decarbonisation technologies and circular economy business in China. ...
Keep your facility up to standard with Guardtech’s Decontamination Team
Cleanroom construction specialists Guardtech Group helping clients shine with their high-performance deep clean programmes ...
Liquid Corporate Finance reduced proposal completion times by four days due to fewer documentation delays
NACFB registered business finance broker, Liquid Corporate Finance (LCF) used to struggle to get deal critical documents back from owner operated business directors in a timely manner. Often out on site, directors could take up to four days to return GDPR statements and Offer Letters. ...
Sketch club - Sketch & Social launches in Cambridge
A bi-weekly meet-up for creatives in and around Cambridge, coming together over sketching in a fun and informal group. ...
Attitudes & approaches to work in Biotech: survey report results 2022
We surveyed people working in Biotech across lab and non lab roles: hear the results of what they'd like more and less of at work ... it looks like change is in the air ...
Why Biotech candidates REALLY move jobs 2022
In 2022 we saw that a high percentage of Biotech candidates had multiple offers. To compete for the right person (and then secure who you want) its essential to know what will make them move roles. ...
IQGeo announces acquisition of Comsof NV
Cambridge - IQGeo, a developer of geospatial software that is “Building better networks” for telecom and utility operators, is pleased to announce the acquisition of Comsof NV (Comsof) and its industry-leading fiber optic network automated planning and design software. The IQGeo Group h...
Origins of germ cell tumours unravelled giving possible opportunities for future treatment
New research has detailed the origins of germ cell tumours, which are derived from the cells that give rise to sperm or eggs. The results shed light on how these tumours develop, and reveal possible future avenues for novel therapies. ...
First map of immune system connections reveals new therapeutic opportunities
A first of its kind comprehensive map of the network of connections that make up the human immune system has been created, which could lead to new immunotherapies to treat cancer, infectious diseases, and other conditions where immune responses play a role. ...
Inspira Pharmaceuticals joins the Lab Hotel at Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst (SBC) welcomes Inspira Pharmaceuticals to its Lab Hotel, a unique facility offering free lab and office accommodation for six months. The start-ups receive scientific and business support, access to SBC’s networks and introductions to investors to help thei...